Combining Antigen-Specific CTLs with Ipilimumab Is Effective in Melanoma [Immunotherapy]

MART1-specific CTLs followed by ipilimumab induce durable tumor regression in patients with melanoma.

from Cancer via ola Kala on Inoreader http://ift.tt/2aYK8ZO
via IFTTT